Cardiothoracic and Vascular Surgeons became the first in Texas to implant the Solo Smart Aortic Pericardial Heart Valve. Faraz Kerendi, M.D. and Stephen J. Dewan M.D., performed the procedure at Heart Hospital of Austin.

CardioDx Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the presentation of the study, "The Use of a Gene Expression Score Showed Clinical Utility in Evaluating African Americans Presenting with Symptoms Suggestive of Obstructive Coronary Artery Disease in a Primary Care Practice," at the 36th annual North American Meeting of the Society for Medical Decision Making, taking place from Oct. 18-22 in Miami.

A research study published in the July issue of the Journal of the American College of Cardiology reports that genetic mutations in a neuronal sodium channel gene are associated with inherited sudden cardiac death syndromes, including the Brugada syndrome. The study, performed at the Cardiac Research Institute at Masonic Medical Research Laboratory (MMRL) in Utica, N.Y., included physicians and scientists from throughout the world who referred patients with life-threatening cardiac arrhythmias to the MMRL for genetic screening.

Infinitt North America will be featuring Dose M 2.0 radiation dose tracking software at this year’s RSNA in Chicago. The new version expands the capture of dose data from multiple-modalities and can be integrated with radiology information systems (RIS), picture archive and communication systems (PACS) or electronic medical records (EMRs) to make dose information accessible as part of the patient record.

Calgary Scientific Inc. has gained U.S. Food and Drug Administration (FDA) clearance of ResolutionMD 4.0 diagnostic medical imaging software for all modalities and China Food and Drug Administration (CFDA) certification for diagnosis on mobile devices in China.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now